Kent Edward Kester
Director · Turn Therapeutics Inc.
Individual
- 2025
- Jun 8, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kent Edward Kester files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Arthur F. Golden - $193K in TTRX purchases and sales in the last 12 months
- Abraham Chesed - $66K in TTRX purchases and sales in the last 12 months
- Zuraiz Chaudhary - $50K in TTRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kent Edward Kester?
Kent Edward Kester is a corporate insider, tracked as Director of Turn Therapeutics Inc. (TTRX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Kent Edward Kester last file a Form 4?
The most recent primary Form 4 on record is dated 8 June 2026, one of 2 filings going back to 2025.
